← Leaderboards
Luis Francisco Zirnberger Batista
Washington University
$6,227,466
Attributed
$6,227,466
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,227,466 · 6
By mechanism
R01$5,245,876 · 4
R00$733,514 · 1
K99$248,076 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Brian Jesse Debosch$7,536,271
- Steven Brody$18,044,181
- Kyunghee Choi$18,130,511
- Michael P Meers$2,437,001
- David A Rudnick$3,126,164
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexCellsPathway InteractionsMolecularMutantMutationTelomeraseResponseLengthTelomereTelomere MaintenanceTelomere ShorteningEventFunctional DisorderHematopoieticFailureIn VitroPhysiologicalPositioning AttributeHuman Embryonic Stem CellCell TypeHuman Pluripotent Stem CellGeneticStem Cells
Grant awards (17)
Mechanisms and relevance of miRNA decay during hematopoietic development$642,478
R01 · FY2025 · HL · contact PI
Uncovering Novel Regulatory Pathways and Functions of the Telomerase RNA Component in the Hematopoietic System$623,874
R01 · FY2025 · HL · contact PI
Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer$360,281
R01 · FY2025 · CA · contact PI
Mechanisms and relevance of miRNA decay during hematopoietic development$657,368
R01 · FY2024 · HL · contact PI
Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer$342,268
R01 · FY2024 · CA · contact PI
Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer$353,076
R01 · FY2023 · CA · contact PI
Telomere dysfunction and telomerase reactivation in the etiology and progression of liver cancer$360,281
R01 · FY2022 · CA · contact PI
MOLECULAR CONSEQUENCES OF TELOMERASE DYSFUNCTION DURING HEMATOPOIETIC DEVELOPMENT$381,250
R01 · FY2021 · HL · contact PI
MOLECULAR CONSEQUENCES OF TELOMERASE DYSFUNCTION DURING HEMATOPOIETIC DEVELOPMENT$381,250
R01 · FY2020 · HL · contact PI
MOLECULAR CONSEQUENCES OF TELOMERASE DYSFUNCTION DURING HEMATOPOIETIC DEVELOPMENT$381,250
R01 · FY2019 · HL · contact PI
MOLECULAR CONSEQUENCES OF TELOMERASE DYSFUNCTION DURING HEMATOPOIETIC DEVELOPMENT$381,250
R01 · FY2018 · HL · contact PI
MOLECULAR CONSEQUENCES OF TELOMERASE DYSFUNCTION DURING HEMATOPOIETIC DEVELOPMENT$381,250
R01 · FY2017 · HL · contact PI
Studying a bone marrow failure disease using patient-specific iPS cells$242,838
R00 · FY2016 · HL · contact PI
Studying a bone marrow failure disease using patient-specific iPS cells$242,838
R00 · FY2015 · HL · contact PI
Studying a bone marrow failure disease using patient-specific iPS cells$247,838
R00 · FY2014 · HL · contact PI
Studying a bone marrow failure disease using patient-specific iPS cells$124,038
K99 · FY2013 · HL · contact PI
Studying a bone marrow failure disease using patient-specific iPS cells$124,038
K99 · FY2012 · HL · contact PI